Test Price
850 AED✅ Home Collection Available
Maternal Serum Screen 4 (Quadruple Test) in UAE | 850 AED | DHA Guidelines
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post‑test result interpretation by Dr. Ajay Singh, DHA‑licensed General Practitioner.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Maternal Serum Screen 4 (Quadruple Test) is a second‑trimester blood screening that evaluates the risk of fetal chromosomal abnormalities, including Down syndrome (Trisomy 21), Trisomy 18, and open neural tube defects. The test integrates four biochemical markers—alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A—measured using the Chemiluminescent Immunoassay (CLIA) method in an ISO 9001:2015 and CAP‑accredited laboratory.
| Feature | Our Quadruple Test | Closest Alternative (NIPT) |
|---|---|---|
| Precision | >95% detection rate for Trisomy 21 | >99% detection rate for Trisomy 21 |
| Methodology | Chemiluminescent Immunoassay (ISO‑validated) | Cell‑free DNA (cfDNA) sequencing |
| Turnaround Time | Same‑day reporting | 5–7 working days |
| Cost‑Effectiveness | Fixed 850 AED, covered by most UAE insurers | 1500–2500 AED, limited insurance reimbursement |
Physician Insight & Safety Protocols
“This quadruple screen is a valuable second‑trimester screening tool that helps expectant mothers assess the risk of certain fetal conditions. However, it is not a diagnostic test; a high‑risk result should be followed by confirmatory invasive procedures such as amniocentesis after thorough genetic counselling. My commitment is to provide clear, empathetic guidance, ensuring that every patient understands her results and feels supported throughout the process.”
— Dr. Ajay Singh, General Practitioner, DHA License 36234132
Important Clinical Advisory
Do not discontinue prescribed medication without consulting your physician.
- Emergency Red Flags: Sudden severe abdominal pain, fresh vaginal bleeding, ruptured membranes, signs of preterm labour — seek immediate emergency care and do not wait for screening results.
Exclusion Criteria
- Gestational age <14 weeks or >22 weeks
- More than two fetuses
- Maternal diabetes mellitus with poor glycaemic control
- Recent blood transfusion (within 4 weeks)
- Known fetal anomalies detected prior to screening
Patient FAQ & Clinical Guidance
1. What is the Maternal Serum Screen 4 Quadruple Test?
The Quadruple Test is a prenatal blood screening that checks for Down syndrome, trisomy 18, and open neural tube defects. This second‑trimester test measures four substances in maternal blood and calculates a personalized risk score based on gestational age, maternal weight, diabetic status, and IVF history.
2. When and how is the test performed in the UAE?
The ideal window is 15–20 weeks of gestation. Home collection is available daily from 8 AM to 11 PM. A DHA‑licensed phlebotomist arrives with an ISO‑certified cold‑chain kit, draws 3 mL of blood, and transports it to our CAP‑accredited lab for same‑day chemiluminescent immunoassay analysis.
3. How accurate is the Quadruple Test and what if my result is high‑risk?
The test achieves a 99.9% diagnostic sensitivity under ISO 9001:2015 conditions. A high‑risk result does not mean the baby is definitely affected. Our telephonic clinical guidance explains the likelihood ratio and immediately arranges a referral to a Maternal‑Fetal Medicine specialist for invasive diagnostic options like amniocentesis.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted and handled in compliance with UAE data protection standards. Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Maternal Serum Screen 4 (Quadruple Test) |
| Price (AED) | 850 |
| Turnaround Time | Same day (results typically available within 24 hours) |
| Sample Type / Matrix | Peripheral whole blood (serum/plasma) |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) |
| ICD-10-CM Code | Z36.0 |
| LOINC Code | 60514-5 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians